share_log

Vivos Therapeutics | EFFECT: Others

Vivos Therapeutics | EFFECT: Others

Vivos Therapeutics | EFFECT:其他
美股sec公告 ·  08/08 06:11
Moomoo AI 已提取核心訊息
Vivos Therapeutics, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of August 7, 2024, at 4:30 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This effectiveness indicates that Vivos Therapeutics has met the necessary regulatory requirements to move forward with its securities offerings.
Vivos Therapeutics, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC) declaring its Form S-3 effective as of August 7, 2024, at 4:30 P.M. The Form S-3 is a registration form that allows companies to provide updated financial information and securities offerings to potential investors. This effectiveness indicates that Vivos Therapeutics has met the necessary regulatory requirements to move forward with its securities offerings.
vivos therapeutics公司是美國的一家上市公司,已經在2024年8月7日下午4:30與證券交易所(SEC)取得了重要的里程碑。 Form S-3 是一種註冊表格,允許公司向潛在投資者提供更新的財務信息和證券發行。此有效性表示Vivos Therapeutics已經滿足了前進證券發行的必要監管要求。
vivos therapeutics公司是美國的一家上市公司,已經在2024年8月7日下午4:30與證券交易所(SEC)取得了重要的里程碑。 Form S-3 是一種註冊表格,允許公司向潛在投資者提供更新的財務信息和證券發行。此有效性表示Vivos Therapeutics已經滿足了前進證券發行的必要監管要求。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息